与伐地那非摄入相关的垂体腺瘤卒中
本文报告一例51岁男性在服用伐地那非后出现头痛和右侧眼肌麻痹,影像学显示鞍上肿块伴出血提示垂体卒中,经蝶窦切除后病理证实为坏死性垂体腺瘤伴出血。报告提示垂体卒中和伐地那非使用之间可能存在关联,对于已有垂体腺瘤的患者,伐地那非可能增加垂体卒中的风险。
要点
- 服用伐地那非后出现头痛和眼肌麻痹时,应将垂体卒中纳入鉴别诊断。
- 本例51岁男性经蝶窦切除后病理证实为坏死性垂体腺瘤伴出血。
- 对于已有垂体腺瘤的患者,伐地那非可能增加垂体卒中的风险。
核心结论
- 本报告提示垂体卒中和伐地那非使用之间可能存在关联。
- 对于已有垂体腺瘤的患者,伐地那非可能增加垂体卒中的风险。
- 服用伐地那非后出现头痛和眼肌麻痹的患者,应将垂体卒中纳入鉴别诊断。
研究设计与样本
- 病例报告:一例51岁男性,服用伐地那非后出现头痛和右侧眼肌麻痹。
主要发现
- 计算机断层扫描和磁共振成像显示鞍上肿块伴出血,提示垂体卒中。
- 患者接受经蝶窦垂体肿块切除术,组织病理学证实为坏死性垂体腺瘤伴出血。
临床怎么用
- 作者认为,对于服用伐地那非后出现头痛和眼肌麻痹的患者,鉴别诊断中应考虑垂体卒中。
- 作者认为,对于已有垂体腺瘤的患者,伐地那非可能增加垂体卒中的风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vardenafil is a potent phosphodiesterase-5 (PDE-5) inhibitor used in the treatment of erectile dysfunction. Several cases of stroke related to the use of PDE-5 inhibitors have been reported. Here, we describe the case of a 51-year-old man with headache and right ophthalmoplegia subsequent to vardenafil consumption. Computed tomography and magnetic resonance imaging showed a suprasellar mass with hemorrhage suggesting pituitary apoplexy. He underwent transsphenoidal resection of the pituitary mass. Histopathology confirmed the diagnosis of a necrotic pituitary adenoma with hemorrhage. This report suggests a possible association between pituitary apoplexy and vardenafil use. In patients with preexisting pituitary adenoma, vardenafil may enhance the risk of pituitary apoplexy. Although headache is the most commonly reported side effect of vardenafil, pituitary apoplexy should be considered in the differential diagnosis of a patient with headache and ophthalmoplegia subsequent to vardenafil intake.
引用
- Uneda A, Hirashita K, Yunoki M, et al. Pituitary adenoma apoplexy associated with vardenafil intake. Acta Neurochir (Wien). 2018. PMID: 30542775. doi:10.1007/s00701-018-3763-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。